The placenta provides essential nourishment and protection to a developing fetus, but new research has suggested that a common cold virus may be able to cross this barrier.
Respiratory syncytial virus: experimental structure-based vaccine candidate shows promise in Phase I trial
Researchers from the University of Texas at Austin have passed an experimental RSV vaccine through Phase I human clinical trial with promising results.
Recently, many programs developing respiratory syncytial virus vaccines have sought to vaccinate pregnant women in an effort to enhance maternal immunity. Find out about the challenges and the latest developments.